Requip is the first drug approved for restless legs syndrome

June 2005

Requip is the first drug approved for restless legs syndrome.

About 10% of Americans get these overpowering urges to move their legs...especially when at rest.

Ropinirole (Requip) is a dopamine agonist...like pramipexole (Mirapex) and pergolide (Permax). They're thought to help by boosting dopamine, a neurotransmitter that controls movement.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote